Meridian Bioscience Inc.

NASDAQ: VIVO · Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM

Meridian Bioscience Revenue

Meridian Bioscience reported an annual revenue of $333.02M, reflecting a 4.76% growth. For the quarter ending December 31, 2022, Meridian Bioscience generated $56.9M in revenue.
Revenue (ttm)
$333.02M
Revenue Growth
4.76%
Price / Sales Ratio
4.17
Revenue / Employee
$482.63K
Employees
690
Market Cap
1.49B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.